Company

Wakamoto Pharmaceutical Co.,Ltd.

Headquarters: Tokyo, Japan

Employees: 403

JPX: 4512 -0.99%

Market Cap

¥8.12 Billion

JPY as of Jan. 1, 2025

US$51.8 Million

Market Cap History

Wakamoto Pharmaceutical Co.,Ltd. Categories

Japan Healthcare Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Wakamoto Pharmaceutical Co.,Ltd. market capitalization over time

Evolution of Wakamoto Pharmaceutical Co.,Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Wakamoto Pharmaceutical Co.,Ltd.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.

Stocks & Indices

Wakamoto Pharmaceutical Co.,Ltd. has the following listings and related stock indices.


Stock: JPX: 4512 wb_incandescent

Details

Headquarters:

2-2-2, Nihonbashi Honcho

Chuo-ku

Tokyo, 103-8330

Japan

Phone: 81 3 3297 0371